Innovation Pharmaceuticals Inc (IPIX)

[ericseb2003]

All comes down to those two trials (P and B), otherwise going to be devastatingly dilutive financing coming down the pike.

With regards to P, speculators are gambling on the P2B exhibiting BOTH:

1) No further increase in toxicity (primarily liver) in spite of patients being dosed with up to double the amount of the already borderline toxic level of the drug.
2) At least equal efficacy in a much broader population base in which arguably arbitrary exclusions will no longer be acceptable.

Btw, saw a Cosentyx commercial for Psoriasis on TV last night, well over 2/3rds of patients skin cleared almost completely, those are some amazing results. Also, 90% improvement if judged by PASI score (after 4 years of treatment)!!!

I think B is best bet, almost a no-brainer going to work for UP (and decent shot it is effective against OM too). Unfortunately, P is huge wild-card, and if fails, then all of CTIX hopes and fortunes are riding on that one drug (Brilacidin).

High risk, high reward. Only invest what you can afford to lose.